Dr. Sarah K Fineberg, MD, PhD
Claim this profileClinical Trials Sarah K Fineberg, MD, PhD is currently running
More about Sarah K Fineberg, MD, PhD
Clinical Trial Related
1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Sarah K Fineberg, MD, PhD has experience with
- MDMA
Breakdown of trials Sarah K Fineberg, MD, PhD has run
Borderline Personality Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sarah K Fineberg, MD, PhD specialize in?
Sarah K Fineberg, MD, PhD focuses on Borderline Personality Disorder and other conditions. In particular, much of their work with Borderline Personality Disorder has involved treating patients, or patients who are undergoing treatment.
Is Sarah K Fineberg, MD, PhD currently recruiting for clinical trials?
Yes, Sarah K Fineberg, MD, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Sarah K Fineberg, MD, PhD has studied deeply?
Yes, Sarah K Fineberg, MD, PhD has studied treatments such as MDMA.
What is the best way to schedule an appointment with Sarah K Fineberg, MD, PhD?
Apply for one of the trials that Sarah K Fineberg, MD, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.